Telomir Pharmaceuticals TELO
NASDAQ TELO
$1.17 -0.03 (-2.50%)
At close: Sep 29, 2026 · 4:00 PM EDT

Telomir Pharmaceuticals (TELO) Receivables - Other (2023 - 2026)

Updated

Telomir Pharmaceuticals' Receivables - Other was $526.00 in Q2 2026.

Analysis

Telomir Pharmaceuticals (TELO) Receivables - Other (2023 - 2026) Analysis & Trends

At the end of FY2025, Receivables - Other at Telomir Pharmaceuticals came in at $318,234.

  • In earlier years, Receivables - Other was $130,000 in FY2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn
10 Telomir Pharmaceuticals 82.53 Mn 82.53 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 526.00
Dec 31, 2025 318,234.00
Sep 30, 2024 130,000.00
Jun 30, 2024 130,000.00
Mar 31, 2024 130,000.00
Dec 31, 2023 130,000.00
API Access

Telomir Pharmaceuticals Receivables - Other API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=receivables-other&ticker=TELO&period=max&api_key=YOUR_API_KEY